Results 241 to 246 of about 79,826 (246)

What is the optimum adjunctive reperfusion strategy for primary percutaneous coronary intervention?

Lancet, The, 2013
Paul A Gurbel, Aung Myat, Deepak L Bhatt
exaly  

6-month versus 12-month or longer dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (SMART-DATE): a randomised, open-label, non-inferiority trial

Lancet, The, 2018
Joo-Yong Hahn, Deok-Kyu Cho, Joon Hyung Doh   +2 more
exaly  

Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 PCI): randomised trial

Lancet, The, 2006
exaly  

Randomised placebo-controlled trial of effect of eptifibatide on complications of percutaneous coronary intervention: IMPACT-II

Lancet, The, 1997
exaly  

Preventive percutaneous coronary intervention versus optimal medical therapy alone for the treatment of vulnerable atherosclerotic coronary plaques (PREVENT): a multicentre, open-label, randomised controlled trial

Lancet, The
Jung-Min Ahn, Do Yoon Kang, Won-Jang Kim
exaly  

Intravascular ultrasound-guided versus angiography-guided percutaneous coronary intervention in acute coronary syndromes (IVUS-ACS): a two-stage, multicentre, randomised trial

Lancet, The
Gary S Mintz, Gregg W Stone
exaly